U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792395) titled 'Ginger's Therapeutic Potential in Asthma' on Aug. 25.
Brief Summary: Primary Objective: The primary endpoint is a clinically significant improvement in tolerance to inhaled methacholine (PD20).
Secondary Objectives: 1) To determine if oral daily ginger extract intake - decreases fractional excretion of nitric oxide; decreases blood eosinophilia; decreases asthma-associated cytokines in serum; decreases medium chain fatty acids; improves asthma symptoms; and 2) Establish pharmacokinetic parameters of biologically active components of ginger in adult asthmatics.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
A...